Cargando...
The Promises and Pitfalls of Reboxetine
The antidepressant compound, morpholine, 2‐[(2‐ethoxyphenoxy)phenylmethyl]‐, methanesulfonate, or reboxetine, is a selective noradrenergic reuptake inhibitor that acts by binding to the norepinephrine (NE) transporter and blocking reuptake of extracellular NE back into terminals. This compound has l...
Gardado en:
| Publicado en: | CNS Drug Rev |
|---|---|
| Autor Principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Blackwell Publishing Ltd
2006
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6741698/ https://ncbi.nlm.nih.gov/pubmed/14647527 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1527-3458.2003.tb00258.x |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|